ASRS 2020: AsclepiX lead candidate holds potential for wet AMD, DME, RVO

Video

Theresa Heah, MD, provides an update on AsclepiX’s AXT107, which is derived from a cryptic peptide within collagen IV that works by activating naturally existing, homeostatic mechanisms of angiogenesis.


Theresa Heah, MD, provides an update on AsclepiX’s AXT107, which is derived from a cryptic peptide within collagen IV that works by activating naturally existing, homeostatic mechanisms of angiogenesis, during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

See more ASRS meeting coverage here

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Recent Videos
At EURETINA 2025, Stela Vujosevic, MD, PhD, FEBO asks, "as part of the symposium on diabetes and vascular disease, "Do we need a new staging for diabetic retinopathy and macular edema?"
Ursula Schmidt-Erfurth, MD,	Professor of Ophthalmology at the Medical University of Vienna, Austria, discusses her keynote EURETINA Lecture, artificial intelligence and age-related macular degeneration.
© 2025 MJH Life Sciences

All rights reserved.